Ophthalmology

Gene therapy shows long-term benefit for treating rare blindness

Pioneering gene therapy has restored some vision to patients with a rare form of genetic blindness for as long as four years, raising hopes it could be used to cure common causes of vision loss, new University of Oxford research ...

Ophthalmology

New sight test detects early AMD

Researchers based at the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Moorfields Eye Hospital and UCL Institute of Ophthalmology designed a new test that can spot the first stages of sight ...

Ophthalmology

New app demystifies glaucoma

Researchers from City University London have developed a highly engaging new app, supported by Allergan Pharmaceuticals, to educate people who have been newly diagnosed with glaucoma about the condition.

Genetics

New form of inherited blindness discovered

Scientists from the University of Leeds, in collaboration with researchers from the Institute of Ophthalmology in London and Ghent University in Belgium, have discovered that mutations in the gene DRAM2 cause a new type of ...

Ophthalmology

Visual hallucinations more common than previously thought

(Medical Xpress)—Vivid hallucinations experienced by people with sight loss last far longer and have more serious consequences than previously thought, according to new research from King's College London and the Macular ...

Ophthalmology

Measuring eye pressure in glaucoma research using iPerfusion

Researchers at Imperial College London have developed a tool that could change our understanding of one of the eye's critical systems. The results, which were part-funded by Fight for Sight, could make it easier to develop ...

page 2 from 3